Nyrada Inc ( ASX: NYR )

  • Apr 20, 2020 AEST
  • Team Kalkine

Nyrada Inc ( ASX: NYR )

Lens through Nyrada’s Neuroprotection Program: Treatment for TBI & Stroke

Australian drug discovery and development company Nyrada Inc. (ASX: NYR) which listed in January, reports solid progress in advancing its two lead R&D programs, one a treatment for brain injury and the other a novel cholesterol lowering drug.

https://kalkinemedia.com/au/news/lens-through-nyradas-neuroprotection-program-treatment-for-tbi-stroke

Nyrada Makes Breakthrough In Brain Injury Program, More Potent Drug Candidates Identified -

The pharmaceutical company, Nyrada Inc. (ASX:NYR) has made reckoning progress in its brain injury program with the discovery of the novel and more potent drug candidates. Following the intravenous administration, the study showed NYX-242 with sufficiently long plasma life readily crosses the brain-blood barrier.

https://kalkinemedia.com/au/flash-news/nyrada-makes-breakthrough-in-brain-injury-program-more-potent-drug-candidates-identified

 

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK